Tiong Mark K, Thomas Sajan, Fernandes David K, Cherian Sajiv
Central Australian Renal Service, Alice Springs Hospital, Alice Springs, Northern Territory, Australia.
Department of Nephrology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Intern Med J. 2022 Feb;52(2):288-294. doi: 10.1111/imj.14960. Epub 2020 Nov 30.
Indigenous Australians are disproportionately affected by end stage kidney disease. Despite this, they face significant delays being assessed and waitlisted for kidney transplant.
To examine the kidney transplant waitlisting process in our region, to compare the workup process between Indigenous Australians and non-Indigenous patients, and identify major sources of delay.
We analysed the records of all patients being treated by our service who were on the kidney transplant waitlist between January 2017 and June 2018. Between-group differences were used to compare the time between commencement of dialysis and completion of each component of assessment. Patients who had more than 1 year between commencement of dialysis and waitlisting were further analysed for major sources of delay.
Twenty-five patients were included (20 Indigenous Australians and 5 non-Indigenous). The median time to waitlisting for transplant after commencing dialysis was significantly longer in the Indigenous group (1215 vs 264 days, P = 0.032). Indigenous Australian patients waited longer before commencing the transplant assessment process and before completing dental assessment, tissue typing and review by the transplant nephrologist and surgeon. Five patients (two Indigenous Australians, three non-Indigenous) were waitlisted within 1 year of commencing dialysis. Among the remaining 20 patients, cardiac and systems issues were the two most common major sources of delay.
Indigenous Australian patients face significant delays accessing the kidney transplant waitlist. Cardiac assessment and systems issues are prominent sources of delay and efforts to address these areas may help to improve equity of access to kidney transplantation.
澳大利亚原住民受终末期肾病的影响尤为严重。尽管如此,他们在接受肾脏移植评估及进入等待名单方面面临显著延迟。
研究我们地区的肾脏移植等待名单流程,比较澳大利亚原住民与非原住民患者的检查过程,并确定主要的延迟来源。
我们分析了2017年1月至2018年6月期间在我们科室接受治疗且在肾脏移植等待名单上的所有患者的记录。采用组间差异来比较透析开始至各项评估完成之间的时间。对透析开始至进入等待名单间隔超过1年的患者进一步分析主要延迟来源。
纳入25例患者(20例澳大利亚原住民和5例非原住民)。开始透析后进入移植等待名单的中位时间在原住民组显著更长(1215天对264天,P = 0.032)。澳大利亚原住民患者在开始移植评估过程前、完成牙科评估、组织配型以及接受移植肾病学家和外科医生复查前等待时间更长。5例患者(2例澳大利亚原住民,3例非原住民)在开始透析后1年内进入等待名单。在其余20例患者中,心脏问题和全身系统问题是两个最常见的主要延迟来源。
澳大利亚原住民患者在进入肾脏移植等待名单方面面临显著延迟。心脏评估和全身系统问题是突出的延迟来源,解决这些方面的努力可能有助于改善肾脏移植的公平可及性。